A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy.
Publication
, Journal Article
Robinson, A; Tangpricha, V; Yow, E; Gurion, R; Schanberg, LE; McComsey, G; APPLE Investigators,
Published in: Arthritis Rheumatol
March 2014
Epidemiologic associations suggest that vitamin D status may play a role in inflammation and progression of atherosclerosis. Using frozen serum, carotid intima medial thickness (CIMT) measurements, and other existing data from the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) trial, we assessed interactions between serum 25-hydroxyvitamin D [25(OH)D], atorvastatin randomization, and CIMT progression rate.
Duke Scholars
Published In
Arthritis Rheumatol
DOI
EISSN
2326-5205
Publication Date
March 2014
Volume
66 Suppl 11
Start / End Page
S47 / S48
Location
United States
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Robinson, A., Tangpricha, V., Yow, E., Gurion, R., Schanberg, L. E., McComsey, G., & APPLE Investigators, . (2014). A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy. Arthritis Rheumatol, 66 Suppl 11, S47–S48. https://doi.org/10.1002/art.38447
Robinson, A., V. Tangpricha, E. Yow, R. Gurion, L. E. Schanberg, G. McComsey, and G. APPLE Investigators. “A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy.” Arthritis Rheumatol 66 Suppl 11 (March 2014): S47–48. https://doi.org/10.1002/art.38447.
Robinson A, Tangpricha V, Yow E, Gurion R, Schanberg LE, McComsey G, et al. A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy. Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S47–8.
Robinson, A., et al. “A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy.” Arthritis Rheumatol, vol. 66 Suppl 11, Mar. 2014, pp. S47–48. Pubmed, doi:10.1002/art.38447.
Robinson A, Tangpricha V, Yow E, Gurion R, Schanberg LE, McComsey G, APPLE Investigators. A31: Vitamin D Status is a Determinant of the Effect of Atorvastatin on Carotid Intima Medial Thickening Progression Rate in Children with Lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus Substudy. Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S47–S48.
Published In
Arthritis Rheumatol
DOI
EISSN
2326-5205
Publication Date
March 2014
Volume
66 Suppl 11
Start / End Page
S47 / S48
Location
United States
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences